Top Markets
#1 QuantixAI QuantixAI +63.61%
#2 Versatize Coin Versatize Coin +40.00%
#3 GEKKO GEKKO +39.64%
#4 UnifAI Network UnifAI Network +30.26%
#5 Prom Prom +30.07%
#6 MowCat MowCat +29.92%
#7 Pons Pons +28.92%
#8 Kinetiq Kinetiq +23.56%
#9 Kinesis Silver Kinesis Silver +23.52%
#10 MarsCoin MarsCoin +21.29%
Coin of the day
QuantixAI QuantixAI
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Rangering i aksjer #20227
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Aksjekurs
$1.91
Markedsverdi
$136.47M
Endring (1 dag)
-1.15%
Endring (1 år)
21.17%
Land
TW
Handel Sinew Pharma Inc. (6634)

Kategori

Healthcare
Inntekter for Sinew Pharma Inc. (6634)
Inntekter i 2026 TTM: 0
Ifølge Sinew Pharma Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Sinew Pharma Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH